Please ensure Javascript is enabled for purposes of website accessibility

Tag Archives: clinical study

Altimmune to start Phase 2 study of intranasal flu vaccine

Altimmune Inc., a Gaithersburg immunotherapeutics company, was cleared by the FDA to start a Phase 2 clinical study of their intranasal flu vaccine. Altimmune says the vaccine, NasoVAX, has the potential to stimulate a broader and quicker immune response than ...

Read More »